| Mullaney's Pharmacy And Home Health | |
| 6096 Montgomery Rd, Cincinnati, Ohio 45213 | |
| (513) 731-1400 |
| Name | Mullaney's Pharmacy And Home Health |
|---|---|
| Organization Name | Mullaney Medical Inc |
| Location | 6096 Montgomery Rd, Cincinnati, Ohio 45213 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (513) 731-1400 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Cardiovascular Systems, Inc. has received FDA approval to complete enrollment of 429 patients in its ORBIT II Investigational Device Exemption clinical trial for a coronary application for its Diamondback 360 System.
Amgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
People who experience job loss, divorce, death of a loved one or any number of life's upheavals often adopt coping mechanisms to make the situation less traumatic.
› Verified 8 days ago
| NPI Number | 1073670014 |
| Organization Name | MULLANEY MEDICAL INC |
| Doing Business As | MULLANEYS LTC PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 6096 Montgomery Rd, Suite B, Cincinnati, OH 45213 |
| Phone Number | 513-587-6202 |
News Archive
Cardiovascular Systems, Inc. has received FDA approval to complete enrollment of 429 patients in its ORBIT II Investigational Device Exemption clinical trial for a coronary application for its Diamondback 360 System.
Amgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
People who experience job loss, divorce, death of a loved one or any number of life's upheavals often adopt coping mechanisms to make the situation less traumatic.
› Verified 8 days ago
| NPI Number | 1225013014 |
| Organization Name | MULLANEY MEDICAL INC |
| Doing Business As | MULLANEY'S PHARMACY & HOME HEALTH CARE |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 6096 Montgomery Rd, Cincinnati, OH 45213 |
| Phone Number | 513-731-1400 |
News Archive
Cardiovascular Systems, Inc. has received FDA approval to complete enrollment of 429 patients in its ORBIT II Investigational Device Exemption clinical trial for a coronary application for its Diamondback 360 System.
Amgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
People who experience job loss, divorce, death of a loved one or any number of life's upheavals often adopt coping mechanisms to make the situation less traumatic.
› Verified 8 days ago
News Archive
Cardiovascular Systems, Inc. has received FDA approval to complete enrollment of 429 patients in its ORBIT II Investigational Device Exemption clinical trial for a coronary application for its Diamondback 360 System.
Amgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
People who experience job loss, divorce, death of a loved one or any number of life's upheavals often adopt coping mechanisms to make the situation less traumatic.
› Verified 8 days ago
Advanced Home Medical Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4460 Lake Forest Dr, Cincinnati, Ohio 45242 Phone: (614) 433-9011 | |
Advanced Orthotic Solutions Llc Type: Medicare Supplier Location: 5820 Ridge Ave, Cincinnati, Ohio 45213 Phone: (513) 628-2407 | |
Bernens Convalescent Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5053 Glenway Ave, Cincinnati, Ohio 45238 Phone: (513) 471-7575 | |
Biorx Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7167 E. Kemper Rd., Cincinnati, Ohio 45249 Phone: (513) 792-7080 | |
Bio Works Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7791 Cooper Rd, Cincinnati, Ohio 45242 Phone: (513) 793-7335 |